Oligodendrocytes are myelin-forming cells in the mammalian central nervous
system. About 50% of oligodendrocytes undergo cell death in normal developm
ent. In addition, massive oligodendrocyte cell death has been observed in m
ultiple sclerosis. Tumor necrosis factor (TNF) is thought to be one of the
mediators responsible for the damage of oligodendrocytes in multiple sclero
sis. The addition of TNF-alpha to primary cultures of oligodendrocytes sign
ificantly decreased the number of live cells in 72 h. DNA fragmentation was
detected in TNF-treated oligodendrocytes at 36 h by TUNEL assay. Chemical
inhibitors Ac-YVAD-CHO (a specific inhibitor of caspase-1 [ICE]-like protea
ses) as well as Ac-DEVD-CHO (a specific inhibitor of caspase-3[CPP32]-like
proteases) enhanced the survival of oligodendrocytes treated with TNF-alpha
, indicating that caspase-1- and the caspase-3-mediated cell-death pathways
are activated in TNF-induced oligodendrocyte cell death. Caspase-11 is inv
olved in activation of caspase-1. Oligodendrocytes from CASP-11-deficient m
ice are partially resistant to TNF-induced oligodendrocyte cell death. Our
results suggest that the inhibition of caspases may be a novel approach to
treat multiple sclerosis.